Symbol="VNDA"
AssetType="Common Stock"
Name="Vanda Pharmaceuticals Inc"
Description="Vanda Pharmaceuticals Inc., a biopharmaceutical company, focuses on the development and commercialization of therapies to address high unmet medical needs. The company is headquartered in Washington, the District of Columbia."
CIK="1347178"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="2200 PENNSYLVANIA AVE NW, SUITE 300E, WASHINGTON, DC, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="341218000"
EBITDA="18703000"
PERatio="21.21"
PEGRatio="-2.42"
BookValue="9.28"
DividendPerShare="0"
DividendYield="0"
EPS="0.28"
RevenuePerShareTTM="4.505"
ProfitMargin="0"
OperatingMarginTTM="0"
ReturnOnAssetsTTM="0.016"
ReturnOnEquityTTM="0.0308"
RevenueTTM="256688000"
GrossProfitTTM="230100000"
DilutedEPSTTM="0.28"
QuarterlyEarningsGrowthYOY="-0.006"
QuarterlyRevenueGrowthYOY="0.038"
AnalystTargetPrice="7"
TrailingPE="21.21"
ForwardPE="30.3"
PriceToSalesRatioTTM="1.532"
PriceToBookRatio="1.153"
EVToRevenue="0.586"
EVToEBITDA="13.6"
Beta="0.694"
num_52WeekHigh="11.1"
num_52WeekLow="5.58"
num_50DayMovingAverage="6.31"
num_200DayMovingAverage="7.53"
SharesOutstanding="57444000"
DividendDate="None"
ExDividendDate="None"
symbol="VNDA"
open="5.80"
high="5.93"
low="5.62"
price="5.64"
volume="790014.00"
latest_trading_day="2023-08-01"
previous_close="5.78"
change="-0.14"
change_percent="-2.4221%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="50"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="50"
Volume_recent_avg="589838"
Change_recent_avg="-0.01"
Delta_recent_avg="0.23"
Variance_recent_avg="0.12"
Change_ratio_recent_avg="-0.26"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="50"
Aroon_momentum_negative="50"
image_negative_thumbnail_id_1="1160"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0194.jpeg"
image_negative_thumbnail_id_2="137"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0039.jpeg"
image_neutral_thumbnail_id_1="592"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0007.jpeg"
image_neutral_thumbnail_id_2="541"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0058.jpeg"
image_positive_thumbnail_id_1="697"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0011.jpeg"
image_positive_thumbnail_id_2="972"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0134.jpeg"
image_professor_thumbnail_id_1="1194"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
image_professor_thumbnail_id_2="1183"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0017.jpeg"
